B
Bolt Biotherapeutics D
D
BOLT
5.70000
USD
-0.08
(-1.38%)
مغلق
حجم التداول
500
الربح لكل سهم
-26
العائد الربحي
-
P/E
-0
حجم السوق
10,926,809
الأخبار المقالات
العنوان: Bolt Biotherapeutics Inc
القطاع: Healthcare
الصناعة: Biotechnology
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.